Douglas L. Huseby, Ph.D.
Affiliations: | 2012 | Biochemistry and Molecular Biology | University of California, Davis, Davis, CA |
Area:
Microbiology BiologyGoogle:
"Douglas Huseby"Parents
Sign in to add mentor| John Roger Roth | grad student | 2012 | UC Davis | |
| (Function of microcompartments in the metabolism of ethanolamine in Salmonella enterica.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Praski Alzrigat L, Huseby DL, Brandis G, et al. (2020) Resistance/fitness trade-off is a barrier to the evolution of MarR inactivation mutants in Escherichia coli. The Journal of Antimicrobial Chemotherapy |
| Garoff L, Pietsch F, Huseby DL, et al. (2020) Population bottlenecks strongly influence the evolutionary trajectory to fluoroquinolone resistance in Escherichia coli. Molecular Biology and Evolution |
| Huseby DL, Brandis G, Praski Alzrigat L, et al. (2020) Antibiotic resistance by high-level intrinsic suppression of a frameshift mutation in an essential gene. Proceedings of the National Academy of Sciences of the United States of America |
| Juhas M, Widlake E, Teo J, et al. (2019) In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumannii. The Journal of Antimicrobial Chemotherapy |
| Vestö K, Huseby DL, Snygg I, et al. (2018) Muramyl Endopeptidase Spr Contributes to Intrinsic Vancomycin Resistance in Serovar Typhimurium. Frontiers in Microbiology. 9: 2941 |
| Garoff L, Huseby DL, Praski Alzrigat L, et al. (2018) Effect of aminoacyl-tRNA synthetase mutations on susceptibility to ciprofloxacin in Escherichia coli. The Journal of Antimicrobial Chemotherapy |
| Pantel L, Florin T, Dobosz-Bartoszek M, et al. (2018) Odilorhabdins, Antibacterial Agents that Cause Miscoding by Binding at a New Ribosomal Site. Molecular Cell. 70: 83-94.e7 |
| Jeannot F, Taillier T, Despeyroux P, et al. (2018) Imidazopyrazinones (IPYs): non-quinolone bacterial topoisomerase inhibitors showing partial cross-resistance with quinolones. Journal of Medicinal Chemistry |
| Huseby DL, Hughes D. (2018) Methods to Determine Mutational Trajectories After Experimental Evolution of Antibiotic Resistance. Methods in Molecular Biology (Clifton, N.J.). 1736: 95-103 |
| Praski Alzrigat L, Huseby DL, Brandis G, et al. (2017) Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli. The Journal of Antimicrobial Chemotherapy |